How supplement fraud slips past a certificate of analysis

In our first article, we discussed the international regulatory clash between U.S. supplement mandates (21 CFR 111) and foreign food/supplement laws. This gap can lead to inadequate dietary ingredient identity verification.

“We review a Certificate of Analysis (CoA) for 100 percent of our globally sourced ingredients.” This is a frequently offered defense by supplements’ brand owners when challenged on international supply chain vulnerabilities. To a physician, this defense sounds like an ironclad guarantee. To an on-the-ground inspector, it is an immediate red flag. Heavy reliance on supplier paperwork (rather than in-house or accredited third-party laboratory verification) creates a “fraud-friendly” environment across international boundaries. When clinicians and brand owners mistake a paper trail for chemical reality, they will be trapped in the CoA myth.

The technical gap: paper vs. laboratories

Standard good manufacturing practice (GMP) checklists are easily fooled by paper compliance. I often observe a staggering gap between verifying a supplier’s CoA and conducting rigorous laboratory testing such as high-performance thin-layer chromatography (HPTLC), high-performance liquid chromatography (HPLC), or DNA verification. Without independent, fit-for-purpose testing on the actual raw powder in the drum, standard facility setups routinely miss three major types of supply chain fraud:

• Sub-ingredient substitution: Cheap, similar-looking compounds are substituted for expensive botanicals. For instance, standard Fourier-transform infrared (FT-IR) spectroscopy cannot cleanly differentiate between chlorella and spirulina. This is a systemic crisis: A recent comprehensive literature review showed that 818 out of 2,995 global botanical samples (over 27 percent) were adulterated or mislabeled. Adulteration rates among common clinical recommendations are alarming: ginkgo leaf (56.7 percent), black cohosh rhizome (42.2 percent), echinacea (28.5 percent), elderberry (17.1 percent), and turmeric (16.5 percent). Strikingly, standard dietary supplements carried a significantly higher risk of fraud than products strictly licensed as registered herbal medicines.
• The wrong plant parts: Bad actors often substitute cheap, useless leaves and stems to cut costs. A prime example is ashwagandha. Despite CoAs and labels claiming “root material only,” suppliers frequently blend in undeclared aerial parts (leaves and stems). Because these cheaper parts share the same marker compounds (withanolides) as the roots, standard assay methods designed to check for the presence of these phytochemicals simply fail to detect the adulteration.
• Synthetic adulteration and “fairy dusting”: Suppliers put a micro-fraction of an active botanical into a batch (just enough to legally list it), then spike the powder with cheap fillers or unlisted synthetic adulterants to falsely “pass” basic chemical assays. Consider a 500 mg proprietary blend of 10 botanicals: Without compositional labeling requirements, one cheap filler might make up 490 mg, leaving the remaining 9 therapeutic ingredients at just 1 mg each.

The clinical risk and practical guide for clinicians

When unverified sub-ingredients bypass independent identity testing, they introduce profound clinical risks. Hidden synthetic adulterants or toxic fillers can cause unexplained liver enzyme spikes, acute hepatotoxicity, or unexpected kidney injury. Furthermore, these compounds can trigger severe drug-drug interactions. An unverified botanical can alter cytochrome P450 enzyme metabolism, causing dangerous therapeutic failure or toxicity in patients taking prescribed anticoagulants, cardiotonics, or immunosuppressants. When a patient presents with an atypical clinical picture or a sudden disruption in a stabilized medication regimen, the culprit is often a paper-perfect, chemically fraudulent supplement.

Recognizing these loopholes is vital, but you operate a clinic, not an analytical testing laboratory. Empowering your patients does not mean becoming a chemist; it means leveraging independent, third-party verification networks that have already done the heavy lifting. When evaluating a brand or a patient’s current regimen, bypass the “paper CoA trap” using these three alternative verification pathways:

1. Screen for independent, lot-specific third-party certifications

Advise patients to look for reputable, independent third-party seals directly on the bottle that mandate physical product testing and facility audits:

• NSF Certified for Sport/NSF Contents Certified: Verifies label accuracy, ensures the product is free of undeclared contaminants, and confirms the facility undergoes physical audits
• U.S. Pharmacopeia (USP) Verified Mark: Confirms specified ingredient potency, proper dissolution for bioabsorption, and freedom from harmful contaminant levels
• ConsumerLab.com or Labdoor: Independent testing clearinghouses that pull products directly off retail shelves to verify active ingredient accuracy and purity

2. Leverage clinical databases over brand marketing

Instead of relying on marketing pamphlets, cross-reference products using objective clinical aggregators:

• The FDA’s list of adulterated and misbranded dietary supplement products
• The National Institutes of Health (NIH) Dietary Supplement Label Database (DSLD)

3. Implement structural supplement history-taking

Mandate a structured “supplement reconciliation” during patient intake:

• Have the patient bring in their physical bottles or message high-resolution photos of the full Supplement Facts panel and lot number.
• Check the bottle for the specific NSF, USP, or ConsumerLab testing seals.
• If a patient taking a noncertified, globally sourced supplement presents with atypical lab work or side effects, instruct them to suspend the supplement immediately to rule out unlisted chemical adulterants.

In the next article, we will reveal the geographic branding trap, tracing the “shadow supply chain” to look at why a “Made in [country]” stamp on a bottle tells you absolutely nothing about where the raw ingredients actually originated.

Alisa Sano is a public health auditor.